A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension

Published:2006-09-21 Issue:11 Volume:22 Page:2095-2100
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Palmer Andrew J.,Valentine William J.,Tucker Daniel M. D.,Ray Joshua A.,Roze Stéphane,Annemans Lieven,Lapuerta Pablo,Chen Roland,Gabriel Sylvie,Carita Paulo,Rodby Roger A.,Zeeuw Dick de,Parving Hans-Henrik,Laville Maurice

Publisher

Informa Healthcare

Subject

General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1185/030079906X132730

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review;BMC Nephrology;2014-01-15

2. Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan;Vascular Health and Risk Management;2013-10

3. Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece;The European Journal of Health Economics;2010-04-22

4. The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus;Nephrology Dialysis Transplantation;2009-07-15

5. Economic Benefits of Treating High-Risk Hypertension with Angiotensin II Receptor Antagonists (Blockers);Clinical Drug Investigation;2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP